Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study

Mario Belvedere, Francesco Violi, Sergio Coccheri, Ettore Marubini, Gian Gastone Neri Serneri

Risultato della ricerca: Articlepeer review

140 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study'. Insieme formano una fingerprint unica.

Medicine & Life Sciences